METROPOLIS

What Metropolis Healthcare promised, and what happened

Every commitment management made on a call, tracked from the quarter it was made — reaffirmed, revised, diluted or quietly dropped.

Guidance record · Q1 FY27

what the last two calls moved 20 tracked 4 delivered 5 missed 11 open
  • Organic EBITDA Margin Expansion delivered said Q4 FY25 Promised: Expect the EBITDA to expand by about 1 percentage in this financial year (FY26). Q1 FY27: Promise completed in FY26. No new update.
  • Overall Revenue Growth missed said Q4 FY25 Promised: We'll be closer to a 26%, 27% growth overall in the year '25, '26. Q1 FY27: Promise completed and missed in FY26. No new update.
  • Core Diagnostics Margin Parity revised up said Q3 FY25 Promised: It will take up to 2 to 3 years to reach the margin Metropolis margin profile. Q1 FY27: Guidance revised again. Target is now 25% margin in 3-4 years from acquisition. This is an improvement from the prior '20%+' target but still below the original 'parity' goal and on an extended timeline.

The rest of the ledger

Above is what the last two calls moved. Pro opens all 20 tracked commitments for Metropolis Healthcare — every quarter's revision, the source quote behind each one, and the topics management has stopped answering.

See what Pro opens